FDA.reportPublic FDA data

leniolisib 70 MG Oral Tablet [Joenja]

RxCUI
2633021
RxNorm name
leniolisib 70 MG Oral Tablet [Joenja]
Display name
leniolisib 70 MG Oral Tablet [Joenja]
Full name
leniolisib 70 MG Oral Tablet [Joenja]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:27

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
eefbcef8-2130-4654-8f29-b58077e08212Joenja 70 MG Oral Tablet [PSN] · leniolisib 70 MG Oral Tablet [Joenja] [SBD] · Joenja 70 MG (equivalent to leniolisib phosphate 85.26 MG) Oral Tablet [SY] · Joenja 70 MG Oral Tablet [SY]46These highlights do not include all the information needed to use JOENJA safely and effectively. See full prescribing information for JOENJA. JOENJA ® (leniolisib) tablets, for oral use Initial U.S. Approval: 202320250605